In this study, the stereo-pathological effect of metformin and N-acetyl cysteine is evaluated on the uterus and ovary of polycystic ovary syndrome (PCOS) mice. 96 mature females (8-weekold, weight of 20–30 gr) BALB/c mice were classified into 6 groups including the control group (n= 16), letrozole-induced PCOS group (n=16), PCOS + metformin (n=16), PCOS+NAC (n=16) and a separate control group for NAC (n=16). Another PCOS group was maintained for a month to make sure that features remain till the end of the study. Testosterone level, vaginal cytology and stereological evaluations were assessed. Vaginal cytology in letrozole-receiving mice showed a diestrus phase continuity. Testosterone level, body weight, uterine weight, endometrial volume, myometrial volume, gland volume, stromal volume, epithelial volume, vessel volume, daughter and conglomerate glands, endometrial thickness, and myometrial thickness exhibited an increasing trend in the uterus of PCOS mice. While normal gland and vessel length decreased in the PCOS group. Ovarian volume, corticomedullary volume, primary follicles, secondary follicles, and ovarian cysts were increased in PCOS ovaries. While corpus luteum, primordial, graafian, and atretic follicles showed a decline in the PCOS group. NAC and metformin, however, managed to restore the condition to normal. Given the prevalence of PCOS and its impact on fertility, the use of noninvasive methods is of crucial significance. NAC can control and treat pathological parameters and help as a harmless drug in the treatment of women with PCOS.

Background: With technological developments, creation of new industries, and changing human behavior and lifestyles, several new infertility risk factors (IRFs) are discovered annually. Although many studies have been conducted on IRFs, no research has yet been carried out on the awareness of Iranian college students about the many IRFs.

Background: Polycystic ovarian syndrome (PCOS) with anovulation, hyperandrogenism, ovarian and uterine histological changes, menstrual irregularities, etc. signs is an infertility type. It seems that melatonin and metformin can improve these abnormalities. Objective: To evaluate the effects of melatonin and metformin on the ovary and uterus in PCOS-induced mice using stereological methods. Materials and Methods: Seventy-two adult female BALB/c mice (8-wk-old, 20-30 gr) were randomly divided into control (distilled water, gavage), PCOS (90 μg/kg letrozole, gavage), PCOS+metformin (500 mg/kg, gavage), PCOS+melatonin (10 mg/kg, intraperitoneal injection), and PCOS+melatonin control (0.5% ethanol saline) groups (n = 12/each). Another PCOS group was kept for a month to ensure that PCOS features remained. Finally, a stereological evaluation of the uterus and ovary was carried out, and vaginal cytology and serum testosterone levels were assessed. Results: PCOS mice treated with metformin and melatonin had lower testosterone levels, body weight, and more regular estrus cycles than the PCOS group (p ≤ 0.001). A significant decrease in conglomerate and daughter gland numbers, and primary, secondary, atretic, and cystic follicles numbers with a significant increase in primordial and Graafian follicles, and corpus luteum numbers (p ≤ 0.001) was seen in these treated mice. Also, endometrial vessels’ volume and length significantly increased, but ovarian, endometrial, myometrial, stromal, and glands volume, and endometrial and myometrial thickness dramatically declined (p ≤ 0.001). Conclusion: It appears that metformin and melatonin could restore the PCOS phenotype including estrus cycle irregularity, high testosterone level, and ovarian and uterine micromorphology to the control levels. However, the 2 treatments had similar effects on the examined parameters. Key words: Polycystic ovarian syndrome, Melatonin, Metformin, Ovary, Uterus, Mice, Stereology.

Ovarian hormones affected some enzymes in reproductive tissues. Previous studies revealed Anethum graveolens (dill) seed extract elevated ovarian hormones. In this study, we compared the effects of dill seed and leaf extracts on some enzymes activities and infertility potential. Female Wistar rats were divided into three groups of control, dill seed and dill leaf aqueous extracts treated groups. Experimental groups received 1 mL of 0.5 g kg ¡1 of each extract orally for 25 days (five estrous cycles). Estradiol, progesterone, luteinizing hormone, and follicle stimulating hormone concentrations were determined. Uterus and ovaries were removed and their glucose-6-phosphate dehydrogenase, lactate dehydrogenase, and alkaline phosphatase activities were measured. Female rats of three groups were mated with untreated males. Fetuses were extracted in the 20th gestational day and their weights and crown rump lengths were measured. Anti-fertility and anti-implantation activities and fertility indices were calculated. Glucose-6-phosphate activity of dill seed treated group increased 1.6 times in the endometrium and 1.7 times in the myometrium. Progesterone concentration and lactate dehydrogenase activity of serum increased in the dill seed treated group compared to the control and dill leaf treated group. A significant decrease was observed in weights and crown rump lengths of fetuses, weights of placenta, and fertility index of the dill seed treated group compared to the control and dill leaf treated group, but its anti-implantation and anti-fertility indices increased. We suggested that high level of glucose-6-phosphate could entail increased oxidative stress in uterus and ovary. High lactate dehydrogenase activity in serum may affect cell membranes. Higher secretion of progesterone caused hormonal imbalance and produced estrous cycle irregularity. It was concluded that dill seed but not dill leaf extract could induce infertility in an animal model.

Due to the increasing use of nanoparticles in medical and industrial fields, concerns are growing about the toxicity of them to the body organs especially the reproductive system. In this review, the effect of metal/metal oxide nanoparticles on the mammalian reproductive system was discussed. Nanoparticles are typically toxic to both males and females, depending on their types, administration method, exposure duration, and surface modification. Regarding the embryo, it was also found that the effect of nanoparticles depends on the embryonic stage exposure during development. However, some nanoparticles, depending on the dose and time of administration, not only did not have toxic effects, but also strengthened the reproductive system and increased its efficiency. As the mode of interaction, penetration, and mechanism of nanoparticles action in the reproductive system is unclear, this review highlights the importance of additional tests in these cases.